News

AddToAny

Google+ Facebook Twitter Twitter

Bat swarming and immunity

Bats carry some of the deadliest zoonotic diseases that can infect both humans and animals, such as Ebola and COVID-19.

The lesser horseshoe bat (Rhinolophus hipposideros)-Image Credit | istock-816193242

A research team has now revealed that some species of bats are protected against the viruses they carry because they commonly exchange immune genes during seasonal mating swarms.

“Understanding how bats have evolved viral tolerance may help us learn how humans can better fight emerging diseases,” said Dr Nicole Foley, from the Texas A&M School of Veterinary Medicine and Biomedical Sciences.

“As genomicists, our work often lays the groundwork for research by scientists who study virus transmission directly. They may be developing vaccines for diseases or monitoring vulnerable animal populations. We all depend on each other to stay ahead of the next pandemic.”

She added: “Several bat species are tolerant of viruses that are detrimental to human health, which means they become reservoirs for disease – they carry the viruses, but don’t develop symptoms.”

The team collaborated with researchers from Ireland, France and Switzerland to sequence the genomes of 60 bat species.

This allowed them to figure out which parts of the DNA represented the species’ true evolutionary history and which parts arose from hybridisation.

The researchers then examined the genetic code and found that immune genes were some of those that were most frequently exchanged between species while swarming.

“Swarming behaviour has always been a bit of a mystery for researchers,” Foley said. “Now we have a better understanding of why this particular behaviour evolved — perhaps to promote hybridisation, which helps spread beneficial immune gene variants more widely throughout the population.”

bit.ly/3T9ncOi

Image Credit | iStock

Related Articles

The big question: Are we entering a new era in which mRNA vaccines are the future?

In May, AstraZeneca began the worldwide withdrawal of its COVID-19 vaccine, due to a “surplus of updated vaccines” that target new variants. Then in June, Moderna announced positive late-stage trial results for its single COVID/flu combination vaccine, mRNA-1083. On the back of this, we look at the future impact of mRNA vaccines.

Breast cancer CREDIT - Science Photolibrary- C0584739

Predicting the return of breast cancer

Dr Isaac Garcia-Murillas discusses a new blood test that can predict if breast cancer will return years before the disease shows on scans.

Restless leg syndrome - CREDIT Science Photolibrary- C0309748

Study points to potential treatments for restless leg syndrome

Scientists have discovered genetic clues to the cause of restless leg syndrome. The discovery could help identify those individuals at greatest risk of the condition and point to potential ways to treat it.

Stem cell transplant and cellular therapy lab

My lab: stem cell transplant and cellular therapy lab

Advanced Specialist Biomedical Scientist Mel Green gives a guided tour of the stem cell transplant lab at Nottingham University Hospitals.

Top